Cargando…
Factor analysis of acute kidney injury in patients administered liposomal amphotericin B in a real-world clinical setting in Japan
Liposomal amphotericin B (L-AMB) is a broad-spectrum antifungal drug that is used to treat fungal infections. However, clinical evidence of its use in patients with renal failure is limited. Here, we aimed to identify factors associated with acute kidney injury (AKI) in patients administered L-AMB....
Autores principales: | Takazono, Takahiro, Tashiro, Masato, Ota, Yuki, Obata, Yoko, Wakamura, Tomotaro, Miyazaki, Taiga, Nishino, Tomoya, Izumikawa, Koichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7490360/ https://www.ncbi.nlm.nih.gov/pubmed/32929112 http://dx.doi.org/10.1038/s41598-020-72135-y |
Ejemplares similares
-
Association between fluid infusions and the recovery from acute kidney injury in patients administered liposomal amphotericin B: a nationwide observational study
por: Tashiro, Masato, et al.
Publicado: (2022) -
Association between potassium supplementation and the occurrence of acute kidney injury in patients with hypokalemia administered liposomal amphotericin B: a nationwide observational study
por: Ota, Yuki, et al.
Publicado: (2021) -
The clinical usage of liposomal amphotericin B in patients receiving renal replacement therapy in Japan: a nationwide observational study
por: Obata, Yoko, et al.
Publicado: (2020) -
Correction to: The clinical usage of liposomal amphotericin B in patients receiving renal replacement therapy in Japan: a nationwide observational study
por: Obata, Yoko, et al.
Publicado: (2021) -
Prognostic Association of Liposomal Amphotericin B Doses Above 5 mg/kg/d in Mucormycosis: A Nationwide Epidemiologic and Treatment Analysis in Japan
por: Tashiro, Masato, et al.
Publicado: (2023)